New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
July 3 – 5, 2017 – Generic versions of Alcon’s Vigamox (moxifloxacin) 0.5% ophthalmic solution were launched.
Download PDF
Return to publications
